Company intelligence / Profile preview

Alican

Istanbul, Turkey

Ownership: Private
Development stage: Other

Overview

Alican is a pet health biotechnology company that specializes in the development of non-invasive diagnostic and monitoring solutions for companion animals. The company's primary focus is on the early detection and management of chronic conditions such as kidney disease and diabetes in cats and dogs through smart monitoring technology. By integrating advanced biosensors with data analytics, Alican provides pet owners and veterinarians with real-time health insights to improve clinical outcomes. Their product suite includes smart litter and diagnostic tools designed to simplify the monitoring of metabolic and physiological markers.

Therapeutic areas: EndocrinologyNephrology
Modalities: DeviceDiagnosticSmall molecule
Industry: Veterinary

Beyond the preview

Go deeper on Alican.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alican.

Explore the full profile